Welcome to LookChem.com Sign In|Join Free

CAS

  • or
GW843682, 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-[2-(trifluoromethyl)-benzyl]oxythiophene-2-carboxamide, is a reversible, cell-permeable inhibitor of polo-like kinases (PLKs), specifically targeting PLK1 and PLK3. It exhibits high selectivity for these kinases over other kinases, such as PDGFR1β, VEGFR2, Aurora A, and Cdk2/cyclin A. GW843682 demonstrates potent inhibitory activity against the growth of various cancer cell lines, inducing G2/M cell cycle arrest and apoptosis in a concentration-dependent manner.

660868-91-7

Post Buying Request

660868-91-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 3-(2-(Trifluoromethyl)benzyloxy)-5-(5,6-dimethoxy-1H-benzo[d]imidazol-1-yl)thiophene-2-carboxamide Manufacturer/High quality/Best price/In stock

    Cas No: 660868-91-7

  • USD $ 3.0-3.0 / Kilogram

  • 1 Kilogram

  • 1-100 Metric Ton/Month

  • Dayang Chem (Hangzhou) Co.,Ltd.
  • Contact Supplier
  • 3-(2-(Trifluoromethyl)benzyloxy)-5-(5,6-dimethoxy-1H-benzo[d]imidazol-1-yl)thiophene-2-carboxamide

    Cas No: 660868-91-7

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier
  • 660868-91-7 GW843682, 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(trifluoromethyl)-benzyl]oxy}thiophene-2-carboxamide

    Cas No: 660868-91-7

  • USD $ 1000.0-1000.0 / Kilogram

  • 1 Kilogram

  • 1 Metric Ton/Day

  • HENAN NEW BLUE CHEMICAL CO.,LTD
  • Contact Supplier
  • GW843682, 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(trifluoromethyl)-benzyl]oxy}thiophene-2-carboxamide

    Cas No: 660868-91-7

  • USD $ 10.0-10.0 / Milligram

  • 1 Milligram

  • 100000000 Kilogram/Month

  • weifang yangxu group co.,ltd
  • Contact Supplier
  • 3-(2-(Trifluoromethyl)benzyloxy)-5-(5,6-dimethoxy-1H-benzo[d]imidazol-1-yl)thiophene-2-carboxamide

    Cas No: 660868-91-7

  • USD $ 1.0-1.0 / Metric Ton

  • 1 Metric Ton

  • 100 Metric Ton/Day

  • Bluecrystal chem-union
  • Contact Supplier

660868-91-7 Usage

Uses

Used in Oncology:
GW843682 is used as a PLK1 and PLK3 inhibitor for the treatment of various types of cancer. It has shown efficacy in inhibiting the growth of multiple cancer cell lines, including human uterine sarcoma cells, drug-resistant cells, and patient-derived leukemia cells. GW843682, 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-[2-(trifluoromethyl)-benzyl]oxythiophene-2-carboxamide's ability to induce cell cycle arrest and apoptosis makes it a promising therapeutic agent for cancer treatment.
Used in Drug Resistance Research:
GW843682 is used as a tool in studying the mechanisms of drug resistance in cancer cells. Its ability to inhibit the growth of drug-resistant cancer cells, such as the P-glycoprotein-expressing MES-SA/Dx5 subline, provides insights into the development of strategies to overcome drug resistance in cancer treatment.
Used in Cancer Cell Line Screening:
GW843682 is used as a screening agent to evaluate the sensitivity of various cancer cell lines to PLK inhibition. Its potency and selectivity for PLK1 and PLK3 make it a valuable tool for identifying cancer cells that are dependent on these kinases for their growth and survival.
Used in Cancer Cell Cycle and Apoptosis Studies:
GW843682 is used as a research compound to investigate the role of PLK1 and PLK3 in the regulation of the cell cycle and apoptosis in cancer cells. Its ability to induce G2/M cell cycle arrest and apoptosis in cancer cells provides valuable information on the molecular mechanisms underlying the anti-cancer effects of PLK inhibition.

Biological Activity

Selective inhibitor of polo-like kinase 1 (PLK1) and polo-like kinase 3 (PLK3) (IC 50 values are 2.2 and 9.1 nM respectively). Displays > 100-fold selectivity over ~30 other kinases tested including cdk1 and cdk2. Inhibits proliferation of most tumor cells in vitro and is selective over normal diploid fibroblasts.

Check Digit Verification of cas no

The CAS Registry Mumber 660868-91-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,6,0,8,6 and 8 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 660868-91:
(8*6)+(7*6)+(6*0)+(5*8)+(4*6)+(3*8)+(2*9)+(1*1)=197
197 % 10 = 7
So 660868-91-7 is a valid CAS Registry Number.

660868-91-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma

  • (G2171)  GW843682X  ≥98% (HPLC), solid

  • 660868-91-7

  • G2171-1MG

  • 1,469.52CNY

  • Detail
  • Sigma

  • (G2171)  GW843682X  ≥98% (HPLC), solid

  • 660868-91-7

  • G2171-5MG

  • 5,908.50CNY

  • Detail

660868-91-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-(5,6-dimethoxybenzimidazol-1-yl)-3-[[2-(trifluoromethyl)phenyl]methoxy]thiophene-2-carboxamide

1.2 Other means of identification

Product number -
Other names Kinome_3462

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:660868-91-7 SDS

660868-91-7Upstream product

660868-91-7Relevant articles and documents

Discovery of thiophene inhibitors of polo-like kinase

Emmitte, Kyle A.,Andrews, C. Webb,Badiang, Jennifer G.,Davis-Ward, Ronda G.,Dickson, Hamilton D.,Drewry, David H.,Emerson, Holly K.,Epperly, Andrea H.,Hassler, Daniel F.,Knick, Victoria B.,Kuntz, Kevin W.,Lansing, Timothy J.,Linn, James A.,Mook Jr., Robert A.,Nailor, Kristen E.,Salovich, James M.,Spehar, Glenn M.,Cheung, Mui

scheme or table, p. 1018 - 1021 (2009/09/06)

The discovery and development of a series of thiophenes as potent and selective inhibitors of PLK is described. Identification and characterization of 2, a useful in vitro PLK inhibitor tool compound, is also presented.

THIOPHENE COMPOUNDS

-

Page 124-125, (2008/06/13)

The present invention provides compounds of formula (I): (I) pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 660868-91-7